Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
STAR Protoc ; 3(2): 101291, 2022 06 17.
Article in English | MEDLINE | ID: mdl-35463475

ABSTRACT

We present a protocol to generate an advanced ex vivo model of human placenta. We use a vibrating tissue slicer to obtain precision-cut slices representative of the entire thickness of human placenta. This approach delivers standardized cultures with a preserved microstructure and cellular composition comparable to the native tissue. We applied this system to study SARS-CoV-2 infection at the maternal-fetal interface. Moreover, this system can be used to investigate the basic functions of the human placenta in health and disease. For complete details on the use and execution of this protocol, please refer to Fahmi et al. (2021).


Subject(s)
COVID-19 , SARS-CoV-2 , Female , Humans , Placenta , Pregnancy
2.
Cell Rep ; 39(4): 110736, 2022 04 26.
Article in English | MEDLINE | ID: mdl-35476995

ABSTRACT

The deacetylase HDAC6 has tandem catalytic domains and a zinc finger domain (ZnF) binding ubiquitin (Ub). While the catalytic domain has an antiviral effect, the ZnF facilitates influenza A virus (IAV) infection and cellular stress responses. By recruiting Ub via the ZnF, HDAC6 promotes the formation of aggresomes and stress granules (SGs), dynamic structures associated with pathologies such as neurodegeneration. IAV subverts the aggresome/HDAC6 pathway to facilitate capsid uncoating during early infection. To target this pathway, we generate designed ankyrin repeat proteins (DARPins) binding the ZnF; one of these prevents interaction with Ub in vitro and in cells. Crystallographic analysis shows that it blocks the ZnF pocket where Ub engages. Conditional expression of this DARPin reversibly impairs infection by IAV and Zika virus; moreover, SGs and aggresomes are downregulated. These results validate the HDAC6 ZnF as an attractive target for drug discovery.


Subject(s)
Influenza A virus , Influenza, Human , Zika Virus Infection , Zika Virus , Histone Deacetylase 6/metabolism , Humans , Influenza A virus/metabolism , Ubiquitin/metabolism , Zika Virus/metabolism
3.
Cell Rep Med ; 2(12): 100456, 2021 12 21.
Article in English | MEDLINE | ID: mdl-34751258

ABSTRACT

The ongoing SARS-CoV-2 pandemic continues to lead to high morbidity and mortality. During pregnancy, severe maternal and neonatal outcomes and placental pathological changes have been described. We evaluate SARS-CoV-2 infection at the maternal-fetal interface using precision-cut slices (PCSs) of human placenta. Remarkably, exposure of placenta PCSs to SARS-CoV-2 leads to a full replication cycle with infectious virus release. Moreover, the susceptibility of placental tissue to SARS-CoV-2 replication relates to the expression levels of ACE2. Viral proteins and/or viral RNA are detected in syncytiotrophoblasts, cytotrophoblasts, villous stroma, and possibly Hofbauer cells. While SARS-CoV-2 infection of placenta PCSs does not cause a detectable cytotoxicity or a pro-inflammatory cytokine response, an upregulation of one order of magnitude of interferon type III transcripts is measured. In conclusion, our data demonstrate the capacity of SARS-CoV-2 to infect and propagate in human placenta and constitute a basis for further investigation of SARS-CoV-2 biology at the maternal-fetal interface.


Subject(s)
Placenta/virology , SARS-CoV-2/physiology , Angiotensin-Converting Enzyme 2/metabolism , COVID-19/transmission , COVID-19/virology , Chorionic Villi/virology , Female , Humans , Infectious Disease Transmission, Vertical , Interferons/metabolism , Placenta/cytology , Placenta/metabolism , Pregnancy , RNA, Viral/metabolism , Trophoblasts/cytology , Trophoblasts/virology , Viral Proteins/metabolism , Virus Release , Virus Replication , Interferon Lambda
4.
PLoS Pathog ; 17(4): e1009529, 2021 04.
Article in English | MEDLINE | ID: mdl-33909707

ABSTRACT

The human respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections in infants, possibly due to the properties of the immature neonatal pulmonary immune system. Using the newborn lamb, a classical model of human lung development and a translational model of RSV infection, we aimed to explore the role of cell-mediated immunity in RSV disease during early life. Remarkably, in healthy conditions, the developing T cell compartment of the neonatal lung showed major differences to that seen in the mature adult lung. The most striking observation being a high baseline frequency of bronchoalveolar IL-4-producing CD4+ and CD8+ T cells, which declined progressively over developmental age. RSV infection exacerbated this pro-type 2 environment in the bronchoalveolar space, rather than inducing a type 2 response per se. Moreover, regulatory T cell suppressive functions occurred very early to dampen this pro-type 2 environment, rather than shutting them down afterwards, while γδ T cells dropped and failed to produce IL-17. Importantly, RSV disease severity was related to the magnitude of those unconventional bronchoalveolar T cell responses. These findings provide novel insights in the mechanisms of RSV immunopathogenesis in early life, and constitute a major step for the understanding of RSV disease severity.


Subject(s)
Lung/immunology , Respiratory Syncytial Virus Infections/immunology , Respiratory Tract Infections/immunology , T-Lymphocytes/pathology , Animals , Animals, Newborn , Cell Differentiation/immunology , Cells, Cultured , Child, Preschool , Disease Models, Animal , Disease Progression , Humans , Lung/growth & development , Lung/pathology , Lung/virology , Respiratory Syncytial Virus Infections/congenital , Respiratory Syncytial Virus Infections/pathology , Respiratory Tract Infections/congenital , Respiratory Tract Infections/pathology , Sheep/growth & development , Sheep/immunology , T-Lymphocytes/immunology , T-Lymphocytes/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...